tiprankstipranks
pc:pre6p

Predicta Biosciences

Predicta Biosciences is a precision oncology company focused on developing innovative diagnostic and therapeutic products. The company specializes in non-invasive diagnostics for blood cancers, particularly multiple myeloma, enabling physicians to assess the likelihood of patient response to immunotherapies. Founded by experts in cancer genomics, Predicta aims to address unmet needs in the diagnosis and prognosis of blood cancers and autoimmune diseases.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$23M
Total Amount Raised$23M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$23M
Latest Funding Amount$23M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 08, 2025
Series A
$23.40M

Related News and Analysis